Ampio Pharmaceuticals' (AMPE -6%) issues a statement intended to reassure shareholders about...

|About: Ampio Pharmaceuticals, Inc. (AMPE)|By:, SA News Editor

Ampio Pharmaceuticals' (AMPE -6%) issues a statement intended to reassure shareholders about their plan to move to the NYSE, but it doesn't seem to be working. The response also attempted to address concerns raised in a Seeking Alpha blog entry recently posted by Greenwich Research that questions the stock's lofty valuation. AMPE states that the article "clearly intended to damage existing shareholders by triggering a downward pressure on their stock holdings."